Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 Mg/ml Solution For Infusion, El(26)a/42
Recall Summary Norgine Pharmaceuticals Limited is recalling specific batches of Pedmarqsi 80 mg/mL solution for infusion in the United Kingdom because testing found a risk of particulate matter (solid particles) in the product. This recall affects patients in the UK who have received or currently have this medication. The recall is classified as Class II, indicating a potential health hazard.
- Recalling firm
- Norgine Pharmaceuticals Limited
- Reason
- Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2026-10-12
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/c95e6583-1346-4801-8afd-869172d0a46c